These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25950807)

  • 1. Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues.
    Cordero-Coma M; Salazar-Méndez R; Yilmaz T
    Expert Opin Drug Saf; 2015 Jul; 14(7):1071-86. PubMed ID: 25950807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.
    Cordero-Coma M; Salazar-Méndez R; Yilmaz T
    Expert Opin Drug Saf; 2015; 14(9):1353-71. PubMed ID: 26118392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.
    Peretz A; Guillaume MP; Casper-Velu L
    Acta Clin Belg; 2002; 57(3):142-7. PubMed ID: 12212355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.
    Salazar-Méndez R; Yilmaz T; Cordero-Coma M
    Expert Opin Investig Drugs; 2016; 25(2):195-214. PubMed ID: 26640977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Options and strategy for the treatment of chronic endogenous uveitis].
    Garweg JG
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):367-72. PubMed ID: 17458817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced uveitis.
    Cordero-Coma M; Salazar-Méndez R; Garzo-García I; Yilmaz T
    Expert Opin Drug Saf; 2015 Jan; 14(1):111-26. PubMed ID: 25323655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy.
    Wakefield D; Abu El-Asrar A; McCluskey P
    Ocul Immunol Inflamm; 2012 Aug; 20(4):277-87. PubMed ID: 22621209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
    Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immunosuppressive agents in uveitis.
    Lustig MJ; Cunningham ET
    Curr Opin Ophthalmol; 2003 Dec; 14(6):399-412. PubMed ID: 14615647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biologic agents in the management of non-infectious uveitis.
    Heo J; Sepah YJ; Yohannan J; Renner M; Akhtar A; Gregory A; Shulman M; Do DV; Nguyen QD
    Expert Opin Biol Ther; 2012 Aug; 12(8):995-1008. PubMed ID: 22780091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies for childhood noninfectious chronic uveitis: an update.
    Cantarini L; Simonini G; Frediani B; Pagnini I; Galeazzi M; Cimaz R
    Expert Opin Investig Drugs; 2012 Jan; 21(1):1-6. PubMed ID: 22074394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of uveitis.
    Smith JR
    Clin Exp Med; 2004 Sep; 4(1):21-9. PubMed ID: 15598082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic severe uveitis: classification, search for etiology and therapeutic approach].
    Bodaghi B; Wechsler B; Du-Boutin LT; Cassoux N; LeHoang P; Piette JC
    Rev Med Interne; 2003 Dec; 24(12):794-802. PubMed ID: 14656639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.
    Vader JP; Froehlich F; Juillerat P; Burnand B; Felley C; Gonvers JJ; Mottet C; Pittet V; Dubois RW; Wietlisbach V; Michetti P
    Digestion; 2006; 73(4):237-48. PubMed ID: 16940727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uveitis research--between disappointment and hope].
    Martenet AC
    Klin Monbl Augenheilkd; 1985 Mar; 186(3):172-4. PubMed ID: 3889476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious uveitis: a review.
    Tabbara KF
    Arch Soc Esp Oftalmol; 2000 Apr; 75(4):215-59. PubMed ID: 11151155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic approaches to autoimmune chronic uveitis in children.
    Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
    Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.